Preliminary laboratory tests conducted by GlaxoSmithKline (GSK)—the maker of the FDA approved over-the-counter weight-loss product— revealed that the counterfeit version did not contain orlistat, the active ingredient in its product. Instead, the counterfeit product contained the controlled substance sibutramine. Sibutramine is a drug that should not be used in certain patient populations or without physician oversight. Sibutramine can also interact in a harmful way with other medications the consumer may be taking.Learn more by reading the recent FDA press release here.
Tuesday, January 19, 2010
FDA warning about counterfeit Alli
If you buy Alli, make sure you're getting the real product. The FDA is warning consumers about counterfeit Alli.